In animal models of AD, including transgenic mice expressing multiple APP mutations [14], 3xTg-AD mice [15], and spontaneously diabetic (OLETF) rats injected with streptozotocin (STZ) [98], decreased tau phosphorylation was observed after oral administration of RSG. The gene discussed is MAPT; the disease is Alzheimer disease.